chapter 11 administration of medication and intravenous therapy

350

Click here to load reader

Upload: rosalind-foster

Post on 25-Dec-2015

393 views

Category:

Documents


9 download

TRANSCRIPT

Page 1: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

CHAPTER 11CHAPTER 11ADMINISTRATION OF MEDICATION

AND INTRAVENOUS THERAPY

Page 2: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 2

PRETESTPRETEST

True or False1. A drug is a chemical that is used for treatment,

prevention, or diagnosis of disease.

2. The generic name of a drug is assigned by the pharmaceutical manufacturer who develops the drug.

3. The Rx symbol comes from the Latin word recipe and means "take."

4. An anaphylactic reaction can be life threatening.

5. The dorsogluteal site is the most common site for administering injections in infants.

Page 3: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 3

PRETEST, CONT.PRETEST, CONT.

True or False6. A subcutaneous injection is given into muscle

tissue.

7. The purpose of aspirating when administering an injection is to make sure the needle is not in a blood vessel.

8. The Mantoux tuberculin test is administered through a subcutaneous injection.

9. The peripheral veins of the arm and hand are used most often for administering IV therapy.

10. Chemotherapy is the use of chemicals to treat disease.

Page 4: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 4

Content OutlineContent Outline

1. Pharmacology: The study of drugs

a. Includes:• Preparation

• Use

• Action of drugs in the body

2. Drug: A chemical that is used for the treatment, prevention, or diagnosis of disease

Introduction to Administration of Medication

Page 5: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 5

Introduction to Administration of Medication, cont.

Introduction to Administration of Medication, cont.

3. Most drugs: produced synthetically

a. Can also be obtained from:• Animals

• Plants

• Minerals

Page 6: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 6

Introduction to Administration of Medication, cont.

Introduction to Administration of Medication, cont.

4. In the office, medication may be:

a. Administered: given to patient at office

b. Prescribed: Physician provides patient with a handwritten or computer-generated prescription to be filled at a pharmacy• Can also be telephoned or faxed to pharmacy

c. Dispensed: Medication given at office for patient to take at home (e.g., drug samples)

Page 7: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 7

Introduction to Administration of Medication, cont.

Introduction to Administration of Medication, cont.

5. Legal Aspects

a. Administer medication only under direction of physician• Unlawful to administer medication without

physician's consent

Page 8: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 8

Introduction to Administration of Medication, cont.

Introduction to Administration of Medication, cont.

6. Routes of Administration

a. Oral

b. Sublingual

c. Inhalation

d. Rectal

e. Vaginal

Page 9: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 9

Introduction to Administration of Medication, cont.

Introduction to Administration of Medication, cont.

f. Topical

g. Intradermal

h. Subcutaneous

i. Intramuscular

j. Intravenous

Page 10: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 10

Introduction to Administration of Medication, cont.

Introduction to Administration of Medication, cont.

7. Route depends on:

a. Type of drug

b. Dosage form

c. Intended action

d. Rapidity of response

desired

Page 11: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 11

Introduction to Administration of Medication, cont.

Introduction to Administration of Medication, cont.

1. Most common route of administration in office:a. Parenteral: Refers to

sites located outside gastrointestinal (GI) tract• Most commonly used to

refer to administration of medication by injection

Page 12: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 12

Introduction to Administration of Medication, cont.

Introduction to Administration of Medication, cont.

9. Drug References

a. For drugs used in office, MA must be familiar with:• Indications

• Adverse reactions

• Route of administration

• Dosage

• Storage

Page 13: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 13

Introduction to Administration of Medication, cont.

Introduction to Administration of Medication, cont.

b. Package insert (PI)• Manufacturer includes with each medication

– Also included with drug samples and injectable medications

• Contains information on the drug

Page 14: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 14

Introduction to Administration of Medication, cont.

Introduction to Administration of Medication, cont.

c. Drug References• Contain drug information

• Example: Physician's Desk Reference (PDR)

– Contains information on major prescription pharmaceutical products available in U.S.

– Consists of actual drug PI

Page 15: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 15

Food and Drug AdministrationFood and Drug Administration

1. Federal agency in DHHS (Department of Health and Human Services)

2. Responsible for:

a. Determining if the following are safe before human use:• New food products

• Vaccines

• Medical devices

• Cosmetics

Page 16: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 16

Food and Drug Administration, cont.

Food and Drug Administration, cont.

3. Determines safety and effectiveness of both prescription and over-the-counter (OTC) drugs

4. Drug manufacturer: must submit application for a new drug to FDA

a. For review and approval

b. Before product can be released for human use

Page 17: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 17

Food and Drug Administration, cont.

Food and Drug Administration, cont.

5. FDA also determines if medication will be available with or without a prescription

a. Prescription drugs: must bear following label:• Caution: Federal law prohibits dispensing

without a prescription

Page 18: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 18

Food and Drug Administration, cont.

Food and Drug Administration, cont.

b. Nonprescription medication: FDA determines to be safe and effective for use without physician supervision• Has low incidence of adverse reactions when

used properly

• Examples:

– Mild pain relievers

– Topical antibiotics

– Topical corticosteroids

– Cold medicines

– Laxatives

Page 19: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 19

Drug NomenclatureDrug Nomenclature

1. Each drug has four names:

a. Chemical Name: precise description of chemical composition• Used most by manufacturers and pharmacists

b. Generic Name: assigned by manufacturer who developed the drug• Often shortened derivative of chemical name

Page 20: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 20

Drug Nomenclature, cont. Drug Nomenclature, cont.

c. Official Name: name under which drug is listed in official publications• Example: U.S. Pharmacopeia (USP)

• Sets standards for each drug to regulate the following:

• Generic name frequently used for official name

- Strength- Purity- Packaging

- Safety- Labeling- Dosage form

Page 21: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 21

Drug Nomenclature, cont. Drug Nomenclature, cont.

d. Brand Name: name under which pharmaceutical manufacturer markets the drug• A drug may be marketed by more than one company

– Generic drug may have several brand names.

– Example:

1) Generic name: acetaminophen

2) Brand names: Tylenol, Tempra, Apacet

Page 22: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 22

Drug Nomenclature, cont.Drug Nomenclature, cont.

e. MA must be familiar with generic and brand name:• For each drug prescribed or administered in

the office

Page 23: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 23

What Would You Do?What Would You Not Do?

What Would You Do?What Would You Not Do?

Page 24: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 24

What Would You Do?What Would You Not Do?

What Would You Do?What Would You Not Do?

Page 25: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 25

Classification of Drugs Based on Preparation

Classification of Drugs Based on Preparation

1. Forms

a. Liquid

b. Solid

Page 26: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 26

Classification of Drugs Based on Preparation, cont.

Classification of Drugs Based on Preparation, cont.

2. Same medications may be available in both liquid and solid form

a. Permits administration to different types of patients

b. Example: antibiotic• Liquid prep: administered to young children

• Solid prep: administered to older children (tablets, capsules)

Page 27: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 27

Liquid PreparationsLiquid Preparations

1. Elixir

a. Drug dissolved in alcohol and water

b. Sweetened and flavored• Example: Dimetapp Elixir

Page 28: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 28

Liquid Preparations, cont. Liquid Preparations, cont.

2. Emulsion

a. Mixture of fats or oils in water• Example: Soyacol Emulsion

Page 29: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 29

Liquid Preparations, cont. Liquid Preparations, cont.

3. Liniment

a. Drug combined with oil, soap, alcohol, or water

b. Applied externally, using friction to produce heat or warmth

c. Example: Heet liniment

Page 30: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 30

Liquid Preparations, cont. Liquid Preparations, cont.

4. Lotion

a. Aqueous preparation that contains suspended ingredients

b. Used to treat external skin conditions• Soothes, protects, and moistens skin

• Destroys harmful bacteria

– Example: Caladryl lotion

Page 31: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 31

Liquid Preparations, cont. Liquid Preparations, cont.

5. Solution

a. Contains one or more completely dissolved substances• Solute: dissolved substance

• Solvent: liquid in which it is dissolved

b. Example: Polysporin ophthalmic solution

Page 32: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 32

Liquid Preparations, cont. Liquid Preparations, cont.

6. Spirit

a. Drug combined with alcohol solution that is volatile: evaporates readily• Example: aromatic spirit of ammonia

Page 33: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 33

Liquid Preparations, cont. Liquid Preparations, cont.

7. Spray

a. Fine spray of medicated vapor

b. Often used for throat and nose conditions

c. Example: Dristan nasal spray

Page 34: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 34

Liquid Preparations, cont. Liquid Preparations, cont.

8. Suspension

a. Drug that contains solid insoluble drug particles in a liquid

b. Must be shaken before administration• Example: Amoxicillin oral suspension

Page 35: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 35

Liquid Preparations, cont. Liquid Preparations, cont.

9. Suspension aerosol

a. Solid or liquid drug particles suspended in a gas

b. Dispensed in a cloud or mist

c. Example: Proventil inhalation aerosol

Page 36: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 36

Liquid Preparations, cont. Liquid Preparations, cont.

10.Syrup

a. Drug dissolved in sugar, water, and flavoring (to disguise unpleasant taste)

b. Example: Robitussin cough syrup

11.Tincture

a. Drug dissolved in alcohol or alcohol and water

b. Example: Tincture of iodine

Page 37: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 37

Solid PreparationsSolid Preparations

1. Tablet

a. Powdered drug that has been pressed into a disc

b. Some are scored: marked with indention so can be broken into halves or quarters for proper dosage

c. Example: Tylenol tablets

Page 38: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 38

Solid Preparations, cont. Solid Preparations, cont.

2. Chewable tablet

a. Powdered drug that has been flavored and pressed into a disc

b. Often used for antacids, antiflatulents, children's medications

c. Example: Pepto-Bismol chewable tablets

Page 39: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 39

Solid Preparations, cont. Solid Preparations, cont.

3. Sublingual tablet

a. Powdered drug that has been pressed into a disc

b. Dissolves under the tongue• Permits rapid absorption into bloodstream

c. Example: nitroglycerin sublingual tablets (Nitrostat)

Page 40: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 40

Solid Preparations, cont. Solid Preparations, cont.

4. Enteric-coated tablet

a. Coated with substance: Prevents tablet from dissolving until it reaches intestines

b. Purpose of coating:• Prevents drug from being destroyed by gastric

juices

• Prevents drug from irritating stomach

c. Must not be crushed or chewed:• Releases active ingredients prematurely in stomach

• Example: Ecotrin enteric-coated aspirin

Page 41: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 41

Solid Preparations, cont. Solid Preparations, cont.

5. Capsule

a. Drug contained in a gelatin capsule that is water-soluble

b. Prevents patient from tasting drug

c. Example: Benadryl capsules

Page 42: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 42

Solid Preparations, cont.Solid Preparations, cont.

6. Sustained-release capsules

a. Contain granules that dissolve at different rates

b. Provides gradual and continuous release of medication

c. Reduces numbers of doses required

d. Example: Contact 12-hour SR capsules

Page 43: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 43

Solid Preparations, cont. Solid Preparations, cont.

7. Caplet

a. Drug contained in oblong tablet

b. Smooth coating for easier swallowing

c. Example: Advil caplets

Page 44: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 44

Solid Preparations, cont. Solid Preparations, cont.

8. Lozenge

a. Drug contained in a candy-like base

b. Circular and dissolves on tongue

c. Example: Chloraseptic throat lozenges

Page 45: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 45

Solid Preparations, cont. Solid Preparations, cont.

9. Cream

a. Drug combined in a nongreasy base

b. Semisolid preparation

c. Applied externally to skin

d. Example: Hydrocortisone topical cream

Page 46: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 46

Solid Preparations, cont. Solid Preparations, cont.

10.Ointment

a. Drug with an oil base

b. Semisolid preparation

c. Applied externally to skin

d. Usually greasy

e. Example: Cortisporin topical ointment

Page 47: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 47

Solid Preparations, cont. Solid Preparations, cont.

11.Suppository

a. Drug mixed with a firm base

b. Melts at body temperature

c. Shaped in cylinder or cone for easy insertion into a body cavity• Rectum

• Vagina

d. Example: Preparation H suppositories

Page 48: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 48

Solid Preparations, cont. Solid Preparations, cont.

12.Transdermal patch

a. Patch with adhesive backing that contains a drug

b. Applied to skin

c. After being absorbed through skin: drug enters circulation• Example: Nictine transdermal patch

(Nicoderm)

Page 49: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 49

Classification of Drugs Based on Action

Classification of Drugs Based on Action

1. Drugs classified according to action they have on body

2. For common drugs administered in office, MA should know:

a. Category to which drug belongs

b. Primary use

c. Major therapeutic effects

Page 50: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 50

Systems of Measurement for Medication

Systems of Measurement for Medication

1. Three systems used in United States for prescribing, administering, and dispensing medication:

a. Metric: used most often because it provides a more exact measurement

b. Apothecary: occasionally used

c. Household: used by patients taking liquid medication at home

Page 51: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 51

Systems of Measurement for Medication, cont.

Systems of Measurement for Medication, cont.

2. Units:

a. Weight: heaviness of an item

b. Volume: amount of space occupied by a substance

c. Length: linear measurement of distance from one point to another• Not used to administer medications

• Used in other aspects of medical office (measure head circumference in centimeters [cm])

Page 52: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 52

Metric SystemMetric System

1. System most often used to administer medications

2. Developed in France in 18th century

3. Pharmaceutical companies: use it to measure and label medications

4. Uniform decimal scale based on units of 10

Page 53: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 53

Metric System, cont. Metric System, cont.

5. Basic units

a. Gram: unit of weight• For measuring solids

b. Liter: unit of volume• For measuring liquids

c. Meter: linear unit• For measuring length and distance

Page 54: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 54

Metric System, cont. Metric System, cont.

6. Units most often used to administer medication:

a. Milligram (weight)

b. Gram (weight)

c. Milliliter (volume)

d. Cubic centimeter: amount of space occupied by 1 ml (1 ml = 1 cc)• These two units can be used interchangeably

Page 55: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 55

Metric System, cont. Metric System, cont.

7. Specific guidelines must be followed in notation of metric units and doses to:

a. Read prescriptions and medication orders

b. Record medication administration

c. Avoid medication errors

Page 56: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 56

Metric System, cont. Metric System, cont.

8. Metric Notation Guidelines

a. Metric unit abbreviations

• Weight

– Microgram: mcg

– Milligram: mg

– Gram: g

– Kilogram: kg

Page 57: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 57

Metric System, cont.Metric System, cont.

• Volume

– Milliliter: ml

– Cubic centimeter: cc

– Liter: L

Page 58: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 58

Metric System, cont. Metric System, cont.

b. Do not use a period with the abbreviation of metric units• May be mistaken for another letter or symbol

– Correct:

1) mg

2) ml

– Incorrect:

1) mg.

2) ml.

Page 59: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 59

Metric System, cont. Metric System, cont.

c. Use Arabic numerals• To express the quantity of the dose

– Correct: 4 mg

– Incorrect: mg (MULTIMEDIA: This needs a line added over the numerals and under the period--see page 456 of the 6th ed)

iv

Page 60: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 60

Metric System, cont. Metric System, cont.

d. Place the numeral that expresses the quantity of the dose in front of the abbreviation• Leave a space between the quantity and the

abbreviation

e. Write a fraction of a dose as a decimal• Correct: 0.5 g

• Incorrect: ½ g

Page 61: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 61

Metric System, cont. Metric System, cont.

f. If the dose is a fraction of a unit:• Place a zero before the decimal point

– Focuses on the fractional dose

– Reduces possibility of misreading the dose as a whole number

• Example:

– Correct: 0.5 g

– Incorrect: .5 g

Page 62: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 62

Metric System, cont. Metric System, cont.

g. Do not place a decimal point and a zero after a whole number• Decimal point may be overlooked: results in

tenfold overdose error

– Correct: 1 ml

– Incorrect: 1.0 ml

Page 63: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 63

Metric System, cont. Metric System, cont.

h. Conversion Equivalents:

• Weight:

– 1000 micrograms = 1 milligram

– 1000 milligrams = 1 gram

– 1000 grams = 1 kilogram

Page 64: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 64

Metric System, cont.Metric System, cont.

• Volume:

– 1000 milliliters = 1 liter

– 1000 liters = 1 kiloliter

– 1 milliliter = 1 cubic centimeter

Page 65: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 65

Apothecary SystemApothecary System

1. Older and less accurate than metric systema. Gradually being phased out for

measurement of medications

2. Developed in England in 18th century

3. Unitsa. Weight

• Grain

• Dram

• Ounce

• Pound

Page 66: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 66

Apothecary System, cont. Apothecary System, cont.

b. Volume• Minim

• Fluid dram

• Fluid ounce

• Pint

• Quart

• Gallon

Page 67: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 67

Apothecary System, cont. Apothecary System, cont.

c. Length• Inch

• Foot

• Yard

• Mile

Page 68: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 68

Household SystemHousehold System

1. Less accurate than metric or apothecary

2. Frequently used in United States

3. May be only system patient can

a. Understand

b. Safely use to take liquid medication at home (e.g., teaspoon)

Page 69: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 69

Household System, cont. Household System, cont.

4. Volume: only household unit used to administer medication

a. Drop (gtt)

b. Teaspoon

c. Tablespoon

d. Ounce

e. Cup

f. Glass

Page 70: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 70

Converting Units of Measurement

Converting Units of Measurement

1. Conversion: changing from one unit of measurement to another

2. Required when medication ordered in a unit different from medication label

Page 71: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 71

Controlled DrugsControlled Drugs

1. Controlled drug: a drug that has restrictions placed on it by the federal government because of its potential for abuse

2. Classified into five categories called schedules

a. Based on abuse potential

Page 72: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 72

Schedule I Schedule I

a. Schedule I• High potential for abuse

• No accepted medical use

• May lead to severe physical or psychological dependence

• Not available for prescribing

• May be used for research with appropriate limitations

Page 73: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 73

Schedule I, cont.Schedule I, cont.

• Examples:

– Heroin

– LSD

– MDMA (Ecstasy)

Page 74: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 74

Schedule II Schedule II

b. Schedule II• High potential for abuse

• Accepted medical use

• Abuse may lead to severe psychological or physical dependence

• Prescription must be in writing

• Emergency telephone order permitted

– Written prescription: must be provided within 7 days

Page 75: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 75

Schedule II, cont.Schedule II, cont.

• No refills allowed

• Manufacturer's label: marked C-II

• Examples:

– Demerol

– OxyContin

– Percocet

– Ritalin

Page 76: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 76

Schedule III Schedule III

c. Schedule III• Intermediate potential for abuse

• Accepted medical use

• Abuse may lead to:

– Low to moderate physical dependence

– Moderate to high psychological dependence

• Telephone and fax orders permitted

Page 77: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 77

Schedule III, cont.Schedule III, cont.

• If authorized by physician:

– Prescription can be refilled:

1) Up to 5 times

2) Within 6 months from issue date

Page 78: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 78

Schedule III, cont. Schedule III, cont.

• Prescription expires 6 months from issue date

• Manufacturer's label: marked C-III

• Examples:

– Tylenol w/ codeine

– Vicodin

Page 79: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 79

Schedule IV Schedule IV

d. Schedule IV• Low potential for abuse

• Accepted medical use

• Abuse may lead to limited physical or psychological dependence

• Telephone and fax orders permitted

Page 80: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 80

Schedule IV, cont. Schedule IV, cont.

• If authorized by physician:

– Prescription can be refilled:

1) Up to 5 times

2) Within 6 months from issue date

Page 81: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 81

Schedule IV, cont. Schedule IV, cont.

• Prescription expires 6 months from issue date

• Manufacturer's label: marked C-IV

• Examples:

– Darvon

– Xanax

– Valium

– Ambien

Page 82: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 82

Schedule V Schedule V

e. Schedule V• Very low potential for abuse

• Accepted medical use

• Abuse may lead to low physical or psychological dependence

Page 83: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 83

Schedule V, cont. Schedule V, cont.

• Prescribing policies determined by state/local regulations

– In most states:

1) Number of refills: determined by physician

2) Prescription expires: 1 year from issue date

3) Some available without prescription to patients >18 years

Page 84: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 84

Schedule V, cont. Schedule V, cont.

• Manufacturer's label: marked C-V

• Examples:

– Cough suppressants with small amounts of codeine

– Antidiarrheals containing paregoric

Page 85: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 85

Controlled Drugs, cont. Controlled Drugs, cont.

3. To administer, prescribe, or dispense controlled drugs:

a. Physician must register annually with Drug Enforcement Administration (DEA)• Assigned a DEA number

• Must put on all prescriptions for controlled drugs

Page 86: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 86

The PrescriptionThe Prescription

1. Physician's order authorizing the dispensing of a drug by a pharmacist

2. Can be authorized in different forms

a. Handwritten

b. Computer-generated

c. Telephoned to pharmacy

d. Faxed to pharmacy

Page 87: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 87

The Prescription, cont. The Prescription, cont.

3. Abbreviations and symbols used to:

a. Write a prescription

b. Record medication info in patient's chart

4. Keep all prescription pads in a safe place

a. Out of reach of individuals who may want to obtain drugs illegally

b. Stock supply should be locked in a drawer

Page 88: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 88

Parts of a PrescriptionParts of a Prescription

1. Date

a. Pharmacist cannot fill prescription without date

b. Prescription expires after a certain length of time after being issued• Usually 1 year except for controlled drugs

c. After prescription expires: cannot be filled (or any refills left on prescription)

Page 89: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 89

Parts of a Prescription, cont. Parts of a Prescription, cont.

2. Physician's name, address, telephone number, and fax number

a. Preprinted on form

b. Identifies physician issuing prescription

c. Provides info if pharmacist has a question and needs to contact office

Page 90: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 90

Parts of a Prescription, cont. Parts of a Prescription, cont.

3. Patient's name and address

a. Used for insurance billing and to properly dispense medications

4. Patient's age

a. Important in dispensing medications:• Pharmacist double-checks physician's order

• Makes sure proper dose is being dispensed based on age

Page 91: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 91

Parts of a Prescription, cont. Parts of a Prescription, cont.

b. Most common errors in dosage occur with elderly and children• Metabolize drugs differently

• May not require the standard dose

c. Also allows pharmacist to make sure drug is age-appropriate• Some drugs should not be taken by a certain

age group

• Example: ciprofloxacin (Cipro) should not be taken by individuals <18 years (can cause cartilage damage)

Page 92: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 92

Parts of a Prescription, cont. Parts of a Prescription, cont.

5. Superscription

a. Rx symbol: Latin for recipe and means "take"

6. Inscription

a. Name of drug and dosage

b. Example: Amoxil 250 mg

Page 93: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 93

Parts of a Prescription, cont. Parts of a Prescription, cont.

7. Subscription

a. Directions to pharmacist• Generally used to designate number of doses

to be dispensed

b. To prevent prescription from being altered:• Use both numbers and letters to indicate

quantity

• Example: #30 (thirty)

Page 94: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 94

Parts of a Prescription, cont. Parts of a Prescription, cont.

8. Signatura (sig)

a. Latin for write or label

b. Indicates information to be included on medication label• Directions for taking medication at home

• Name of medication

Page 95: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 95

Parts of a Prescription, cont. Parts of a Prescription, cont.

9. Refill

a. Number of times medication can be refilled

10.Physician's signature

a. Prescription cannot be filled without physician's signature

11.DEA number

a. Must appear on prescription for a controlled drug

Page 96: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 96

Parts of a PrescriptionParts of a Prescription

Page 97: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 97

Generic PrescribingGeneric Prescribing

1. Physician writes prescription using generic namea. Pharmacist can fill prescription with drug that

offers best savings to patient

2. Physician writes prescription using brand namea. In most states pharmacist has option of filling

prescription with a generic drug

3. Physician wants prescription to be filled with a specific brand:a. Must indicate Dispense as Written (DAW) on

prescription form

Page 98: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 98

Completing a Prescription Form

Completing a Prescription Form

1. If delegated by physician: MA can complete prescription form

a. Physician must thoroughly review: to make sure info is correct

b. Physician signs form

2. MA must carefully follow prescription writing guidelines

Page 99: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 99

The Medication RecordThe Medication Record

1. Office may use a preprinted form

2. Medications that should be recorded:

a. Prescription

b. Over-the-counter

c. Vitamin supplements

d. Herbal products

Page 100: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 100

The Medication Record, cont.The Medication Record, cont.

3. Detailed information included for each medicationa. Informs physician what patient is taking and how

much

4. Should be part of every patient's medical record

5. MA may be responsible for documenting medication information

6. Medication record includes:a. Patient's name and date of birth

b. Any drug allergies

Page 101: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 101

The Medication Record, cont. The Medication Record, cont.

c. Date medication prescribed (Rx) or date patient started taking (over-the-counter)

d. Name and dosage of medication

e. Frequency of administration

f. Route of administration

g. Whether prescription or over-the-counter

h. Refills (prescription medication only)

i. Date patient stopped taking medication

Page 102: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 102

Medication RecordMedication Record

Page 103: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 103

Factors Affecting Drug ActionFactors Affecting Drug Action

1. Each medication has an intended therapeutic effect

2. Certain factors affect action of drug in the body

a. Causes patients to respond differently to same drug

b. Drug therapy may need to be adjusted to meet variations

Therapeutic Effect

Page 104: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 104

Therapeutic Effect, cont. Therapeutic Effect, cont.

3. Factors affecting drug action

a. Age• Children and elderly: respond more strongly

to drugs than adults

– Smaller dose may be prescribed

Page 105: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 105

Therapeutic Effect, cont Therapeutic Effect, cont

b. Route of Administration• Medication administered by different routes:

absorbed at different rates

• Oral: absorbed slowly

– Must first be digested

• Parenteral: absorbed more quickly than oral

– Injected directly into body

Page 106: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 106

Therapeutic Effect, cont Therapeutic Effect, cont

c. Size• Thin person: may require smaller drug

quantity

• Obese person: may require larger drug quantity

d. Time of Administration• Empty stomach: oral drug absorbed more

rapidly

• After eating: oral drug absorbed slower

• If medication irritating to stomach: take with food

Page 107: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 107

Therapeutic Effect, cont.Therapeutic Effect, cont.

e. Tolerance• Same dose of a drug no longer produces

desired effect

• Patient should notify physician

– Change in drug or dosage may be needed

Page 108: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 108

Undesirable Effects of DrugsUndesirable Effects of Drugs

1. May occur immediately or delayed hours or days

2. Includes:

a. Adverse Reactions• Unintended and undesirable effects that occur

along with therapeutic effects

– May be harmful: warrant discontinuing medication (e.g., allergic reaction)

– May be harmless: referred to as side effects:

Page 109: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 109

Undesirable Effects of Drugs, cont.

Undesirable Effects of Drugs, cont.

• Side effects: adverse reactions that are harmless and often tolerated by patient to obtain therapeutic effect

– Example: dry mouth when taking an antihistamine

b. Drug Interactions• May occur when certain drugs are taken at

same time

• Ask patient what medications he/she is taking

– Record information in chart for review by physician

Page 110: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 110

Undesirable Effects of Drugs, cont.

Undesirable Effects of Drugs, cont.

c. Allergic Drug Reaction• Often mild: rash, rhinitis, pruritus

• Anaphylactic reaction: A serious allergic reaction that requires immediate treatment

– Least common but most serious

– Occurs suddenly

Page 111: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 111

Undesirable Effects of Drugs, cont.

Undesirable Effects of Drugs, cont.

– Symptoms of Anaphylactic Reaction

1) Sneezing

2) Urticaria (hives)

3) Itching

4) Angioedema: a localized urticaria of the deeper tissues of the body

5) Erythema: Reddening of the skin caused by dilation of superficial blood vessel in the skin

6) Disorientation

Page 112: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 112

Undesirable Effects of Drugs, cont.

Undesirable Effects of Drugs, cont.

Symptoms of Anaphylactic Reaction:

– If no treatment, symptoms increase and progress to:

1) Dyspnea

2) Cyanosis

3) Shock

4) Decreased blood pressure

5) Weak and thready pulse

Page 113: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 113

Undesirable Effects of Drugs, cont.

Undesirable Effects of Drugs, cont.

Symptoms of Anaphylactic Reaction

– If treatment not initiated promptly:

1) Convulsions

2) Loss of consciousness

3) Death

Page 114: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 114

Undesirable Effects of Drugs, cont.

Undesirable Effects of Drugs, cont.

– To prevent anaphylactic reaction:

1) Stay with patient after administration of medications

2) Be especially alert after administering:a) Allergy test

b) Penicillin

c) Allergy injections

Page 115: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 115

Undesirable Effects of Drugs, cont.

Undesirable Effects of Drugs, cont.

– Notify physician immediately if anaphylactic reaction occurs

– Treatment

1) One or more injections of epinephrine

2) Once patient is stabilized: antihistamine injection

a) Reverses the life-threatening symptoms

a) Alleviates urticaria, itching, angioedema, erythema

Page 116: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 116

Undesirable Effects of Drugs, cont.

Undesirable Effects of Drugs, cont.

d. Idiosyncratic Reaction• Abnormal or peculiar response to a drug that

is unexplained and unpredictable

• Most often occurs in elderly patients

Page 117: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 117

What Would You Do?What Would You Not Do?

What Would You Do?What Would You Not Do?

Page 118: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 118

What Would You Do?What Would You Not Do?

What Would You Do?What Would You Not Do?

Page 119: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 119

Guidelines for Preparation and Administration of Medication

Guidelines for Preparation and Administration of Medication

1. Work in quiet, well-lit atmosphere free from distractions

2. Always ask if you have a question about a medication order

3. Know drug to be given

Page 120: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 120

Guidelines for Preparation and Administration of Medication,

cont.

Guidelines for Preparation and Administration of Medication,

cont.

4. Select proper drug

a. Check label three times• When taking it from storage

• Before preparing medication

• After preparing medication

b. Do not use if label is missing or difficult to read

Page 121: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 121

Check the Drug LabelCheck the Drug Label

Page 122: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 122

Guidelines for Preparation and Administration of Medication,

cont.

Guidelines for Preparation and Administration of Medication,

cont.

5. Do not use drug if:

a. Color has changed

b. Precipitate has formed

c. Unusual odor present

Page 123: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 123

Guidelines for Preparation and Administration of Medication,

cont.

Guidelines for Preparation and Administration of Medication,

cont.

1. Check expiration date

Page 124: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 124

Guidelines for Preparation and Administration of Medication,

cont.

Guidelines for Preparation and Administration of Medication,

cont.

7. Prepare proper dose

a. Dose: the quantity of a drug to be administered at one time• Dose too small: will not produce therapeutic

effect

• Dose too large: could be harmful or fatal

b. Dosage range: range of quantities of the drug that can produce therapeutic effects

Page 125: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 125

Guidelines for Preparation and Administration of Medication,

cont.

Guidelines for Preparation and Administration of Medication,

cont.

8. Identify the patient

a. By full name and date of birth

9. Make sure patient not allergic to medication by:

a. Checking patient's record

b. Questioning patient

Page 126: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 126

Guidelines for Preparation and Administration of Medication,

cont.

Guidelines for Preparation and Administration of Medication,

cont.

10.If giving injection: determine route and site

a. Determined by the type of injection

b. Examples:• Allergy injection: administered subcutaneously

(SC)

• Antibiotic: administered intramuscularly (IM)

Page 127: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 127

Guidelines for Preparation and Administration of Medication,

cont.

Guidelines for Preparation and Administration of Medication,

cont.

c. Site must be free from:• Abrasions

• Lesions

• Bruises

• Edema

11.Use proper technique

Page 128: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 128

Guidelines for Preparation and Administration of Medication,

cont.

Guidelines for Preparation and Administration of Medication,

cont.

12.Stay with patient after administration

13.Document information in patient's chart: must be clear and legible

a. Date and time

b. Name of medication and lot number (if required)

Page 129: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 129

Guidelines for Preparation and Administration of Medication,

cont.

Guidelines for Preparation and Administration of Medication,

cont.

c. Dose given• If dose contains a fraction of a unit: place a 0

before decimal point

– Example: 0.5 mg (not .5 mg)

• Never place a decimal point and a zero after a whole number

– Example: 20 mg (not 20.0 mg)

– So not misread as 200 mg

Page 130: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 130

Guidelines for Preparation and Administration of Medication,

cont.

Guidelines for Preparation and Administration of Medication,

cont.

d. Route of administration

e. Site of administration

f. Any unusual observations or patient reactions

g. Sign record with your name and credentials

Page 131: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 131

Slide TitleSlide Title

Page 132: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 132

Guidelines for Preparation and Administration of Medication,

cont.

Guidelines for Preparation and Administration of Medication,

cont.

14.Always follow seven "rights" of preparing and administering medication

a. Right drug

b. Right dose

c. Right time

d. Right patient

e. Right route

f. Right technique

g. Right documentation

Page 133: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 133

Oral AdministrationOral Administration

1. Most convenient and most common method to administer medication

2. Drug is given by mouth (po) in solid or liquid form

3. Absorption of most oral drugs: small intestine

Page 134: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 134

Oral Administration, cont.Oral Administration, cont.

1. Easier for many patients to swallow tablet/capsule with a glass of water

2. Water should not be offered if patient has taken cough syrupa. Water dilutes

beneficial effects

Page 135: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 135

Parenteral AdministrationParenteral Administration

1. Advantages (SC, IM, IV):

a. Absorbed more rapidly and completely than oral route

b. May be only way drug can be given• Unconscious patient

• Gastric disturbance

– Nausea

– Vomiting

Page 136: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 136

Parenteral Administration, cont.

Parenteral Administration, cont.

2. MA usually responsible for administering SC, IM, intradermally (ID)

a. Intravenous administration: when immediate effect is needed• Usually administered by physician in

emergency situation

Page 137: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 137

Parenteral Administration, cont.

Parenteral Administration, cont.

3. Disadvantages

a. Pain• To minimize pain of an injection:

– Insert and withdraw needle quickly and smoothly

– Withdraw needle at same angle as that of insertion

b. Possibility of infection at injection site

Page 138: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 138

Parenteral Administration, cont.

Parenteral Administration, cont.

4. Injections that are given repeatedly: must rotate sites (e.g., allergy injections):

a. Prevents overuse of one site: • Can cause irritation and tissue damage

b. Allows better absorption of drug

Page 139: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 139

Parenteral Administration, cont.

Parenteral Administration, cont.

5. Recording administration of medication in patient's chart:

a. Record site of administration • Assists in proper rotation of sites

– For injections given repeatedly

• Provides reference point if problem arises

Page 140: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 140

Parenteral Administration, cont.

Parenteral Administration, cont.

6. Use medical asepsis when administering medications (Needle and inside syringe must remain sterile)

a. Reduces danger of microorganisms entering patient's body

7. Follow OSHA Bloodborne Pathogens Standard

a. To Protect MA from bloodborne pathogens

Page 141: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 141

Parts of a NeedleParts of a Needle

1. Needle

a. Hub: fits onto top of syringe

b. Shaft: inserted into body tissue

c. Lumen: opening in shaft of needle

Page 142: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 142

Parts of a Needle, cont. Parts of a Needle, cont.

d. Point: located at end of needle shaft• Sharp: to easily penetrate body tissues

e. Bevel: located at top and slanted• Makes narrow, slitlike opening in skin

– Closes quickly to prevent leakage of medication

– Heals quickly

Page 143: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 143

Parts of a Needle and SyringeParts of a Needle and Syringe

Page 144: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 144

Parts of a Needle, cont. Parts of a Needle, cont.

f. Gauge• Range: between 18 and 27

• Refers to diameter of lumen

• As size of gauge increases, diameter decreases

• Thick, oily medications: must be given with a large lumen

– Too thick to pass through a smaller one

• Large lumen: makes a larger needle track in tissue

– Use smallest gauge needle possible: to reduce pain and tissue damage

Page 145: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 145

Parts of a Needle, cont. Parts of a Needle, cont.

g. Length• Range: between ⅜ and 3 inches

• Based on type of injection given (IM, SC, ID) and size of the patient

-Example: Giving an IM injection to an obese adult: requires a longer need to reach muscle tissue

• Length of needle: must be longer for IM injection

– To penetrate to muscle tissue

Page 146: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 146

Parts of a Syringe Parts of a Syringe

2. Syringe

a. Used for inserting fluids into body

b. Made of plastic

c. Disposable

d. Syringe with attached needle packaged in:• Cellophane wrapper

• Rigid plastic container

Page 147: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 147

Parts of a Syringe, cont. Parts of a Syringe, cont.

e. Printed on wrapper: • Syringe capacity

• Needle length

f. Syringe/needle in separate packages: must attach needle to syringe

Page 148: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 148

Syringe and Needle PackagesSyringe and Needle Packages

Page 149: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 149

Parts of a Syringe, cont. Parts of a Syringe, cont.

g. Parts of a Syringe

• Barrel: holds medication

– Contains calibrated markings to measure proper amount

1) Most syringes calibrated in cubic centimeters (cc)

Page 150: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 150

Parts of a Syringe, cont. Parts of a Syringe, cont.

• Flange: rim at the end of the barrel

– Helps in injecting medication

– Prevents syringe from rolling when placed on flat surface

• Plunger: moveable cylinder that slides back and forth in the barrel

– Used to draw medication into and out of syringe

Page 151: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 151

Parts of a SyringeParts of a Syringe

Page 152: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 152

Hypodermic Syringe Hypodermic Syringe

h. Types of syringes: choice based on type of injection

• Hypodermic syringe

– Calibrated in cc

– Available in 2, 2.5, 3, and 5 cc

1) Commonly used to administer IM injections

Page 153: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 153

Hypodermic SyringeHypodermic Syringe

Page 154: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 154

Insulin Syringe Insulin Syringe

• Insulin syringe

– Designed to administer insulin injections

– Calibrated in units

1) Most common: U-100

Page 155: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 155

Insulin SyringeInsulin Syringe

Page 156: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 156

Tuberculin Syringe Tuberculin Syringe

• Tuberculin syringe

– To administer very small dose of medication (e.g., tuberculin test)

– Capacity of 1 cc

– Calibrations divided into tenths and hundredths of a cc

Page 157: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 157

Tuberculin SyringeTuberculin Syringe

Page 158: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 158

Parts of a SyringeParts of a Syringe

i. Syringes also available in 10, 20, 30, 50, and 60 cc• Not used to administer medication

• Used for medical treatment

– Irrigating wounds

– Drawing fluid from cysts

Page 159: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 159

Safety-Engineered SyringesSafety-Engineered Syringes

1. OSHA stipulates requirements to:

a. Reduce needlesticks and other sharps injuries among health care workers

2. Employers are required to evaluate and implement safer medical devices

3. Safety-engineered syringes: built-in safety feature to reduce risk of needlestick injury

Page 160: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 160

Safety Engineered SyringeSafety Engineered Syringe

Page 161: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 161

Safety Engineered SyringeSafety Engineered Syringe

Page 162: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 162

Preparation of Parenteral Medication: Vial

Preparation of Parenteral Medication: Vial

1. Vials

a. Closed glass container with a rubber stopper

b. Soft metal or plastic cap• Protects the rubber stopper

• Must be removed first time medication is used

Page 163: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 163

Preparation of Parenteral Medication: Vial, cont.

Preparation of Parenteral Medication: Vial, cont.

a. Available• Single-dose

• Multiple-dose

Page 164: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 164

Preparation of Parenteral Medication: Vial, cont.

Preparation of Parenteral Medication: Vial, cont.

b. Vial may require mixing• Examples:

– Reconstituting a powdered drug

– Mixing vial that separates on standing

• Roll medication between hands

• Do not shake: causes bubbles that may enter syringe

Page 165: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 165

Rolling VialRolling Vial

Page 166: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 166

Preparation of Parenteral Medication: Vial, cont.

Preparation of Parenteral Medication: Vial, cont.

e. To remove medication from vial:• Inject amount of air equal

to amount of liquid to be removed

– Prevents formation of a partial vacuum: makes it difficult to remove medication

Page 167: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 167

Preparation of Parenteral Medication: Vial, cont.

Preparation of Parenteral Medication: Vial, cont.

• Inject air above fluid level

– Prevents getting air bubbles into medication

Page 168: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 168

Preparation of Parenteral Medication: Vial, cont.

Preparation of Parenteral Medication: Vial, cont.

• Remove medication by inserting needle opening below fluid level

– Prevents air bubbles from entering syringe

• Draw up correct amount of medication

Page 169: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 169

Preparation of Parenteral Medication: Vial, cont.

Preparation of Parenteral Medication: Vial, cont.

• Remove air bubbles from syringe by tapping barrel with fingertips

– Air bubbles take up space medication should take up: prevents patient from receiving full dose of medication

Page 170: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 170

Preparation of Parenteral Medication: Ampule, cont. Preparation of Parenteral Medication: Ampule, cont.

2. Ampule

a. Small, sealed glass container

b. Holds a single dose of medication

c. Constriction in the stem (neck): helps in opening it

d. Make sure no medication in stem: tap it lightly

e. Colored ring around neck: indicates where ampule is prescored• For easy opening

Page 171: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 171

Preparation of Parenteral Medication: Ampule, cont. Preparation of Parenteral Medication: Ampule, cont.

f. Open by holding firmly with gauze and breaking off stem• Use a strong steady

pressure

Page 172: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 172

Preparation of Parenteral Medication: Ampule, cont. Preparation of Parenteral Medication: Ampule, cont.

g. Hazard with ampule• Small glass particles can get into ampule:

when stem broken off

• Prevent this by using filter needle to withdraw medication

Page 173: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 173

Preparation of Parenteral Medication: Ampule, cont. Preparation of Parenteral Medication: Ampule, cont.

h. Remove medication from ampule• Do not let needle touch outside of ampule

– Prevents contamination of needle

• Do not inject air into ampule

– Could force out medication

Page 174: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 174

Preparation of Parenteral Medication: Ampule, cont.Preparation of Parenteral Medication: Ampule, cont.

• Insert needle below fluid level

• Withdraw medication

Page 175: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 175

Preparation of Parenteral Medication, cont.

Preparation of Parenteral Medication, cont.

3. Prefilled syringes and cartridges

a. Disposable

b. Do not have to draw up medication

Page 176: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 176

Preparation of Parenteral Medication, cont.

Preparation of Parenteral Medication, cont.

c. Info printed on syringe/cartridge:• Name of drug

• Dose

• Expiration date

– Example: Tubex injector

Page 177: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 177

Storage of MedicationsStorage of Medications

1. Store properly following info in drug package insert

2. Improper storage may alter effectiveness of medication

Page 178: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 178

Reconstitution of Powdered Drugs

Reconstitution of Powdered Drugs

1. Some medications stable for only short period of time in liquid form

a. Example: measles, mumps, and rubella (MMR) immunization

b. Must be prepared and stored in powdered form

Page 179: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 179

Reconstitution of Powdered Drugs, cont.

Reconstitution of Powdered Drugs, cont.

2. Liquid added to powder to reconstitute medication

a. Diluent: liquid used to reconstitute• Usually sterile water or

normal saline

Page 180: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 180

Reconstitution of Powdered Drugs, cont.

Reconstitution of Powdered Drugs, cont.

3. Powdered drug available in:

a. Single-dose vial

b. Multi-dose vial

4. Instructions provided for reconstituting medication

Page 181: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 181

Subcutaneous InjectionsSubcutaneous Injections

1. Administered into subcutaneous tissue

a. Consists of adipose (fat) tissue• Located just under the skin

b. SC tissue: located all over body• Certain sites more commonly used

– Where bones and blood vessels are not near surface of skin

Page 182: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 182

Subcutaneous Injections, cont. Subcutaneous Injections, cont.

2. SC sites commonly used:

a. Upper lateral part of arms

b. Anterior thigh

c. Upper back

d. Abdomen

Page 183: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 183

Subcutaneous Injection SitesSubcutaneous Injection Sites

Page 184: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 184

Subcutaneous Injections, cont. Subcutaneous Injections, cont.

1. Angle of insertion: 45 or 90 degrees

Page 185: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 185

Subcutaneous Injections, cont. Subcutaneous Injections, cont.

4. Medication is absorbed through capillaries

a. Slower absorption rate than IM

5. Do not give SC injection into tissue that is

a. Grossly adipose

b. Hardened

Page 186: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 186

Subcutaneous Injections, cont.Subcutaneous Injections, cont.

c. Inflamed

d. Edematous• May interfere with proper absorption

6. Needle length range: ½ to ⅝ inch

a. Use 45-degree angle of insertion with ⅝-inch needle

b. Use 90-degree angle of insertion with ½-inch needle

Page 187: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 187

Subcutaneous Injections, cont. Subcutaneous Injections, cont.

7. Needle gauge range: 23 to 25

8. Use proper length needle: to make sure medication is administered into SC tissue

a. Elderly and dehydrated patients: have less SC tissue• Use shorter needle

b. Obese patients: have more SC tissue• Use longer needle

Page 188: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 188

Subcutaneous Injections, cont. Subcutaneous Injections, cont.

9. SC tissue is sensitive to:

a. Irritating solutions

b. Large volumes of

medication

Page 189: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 189

Subcutaneous Injections, cont. Subcutaneous Injections, cont.

10.Any medication given SC must be:

a. Isotonic

b. Nonirritating

c. Nonviscous

d. Water soluble

e. Should not exceed 1 cc• More than 1 cc: causes discomfort and pain

– Due to pressure on sensory nerve endings

Page 190: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 190

Subcutaneous Injections, cont. Subcutaneous Injections, cont.

11.Medications administered SC:

a. Epinephrine

b. Insulin

c. Allergy injections• Following injection: patient must wait 15 to 20

minutes

– To be observed for a reaction

• If patient decides not to wait: must sign a waiver form

– To protect office legally in the event of an allergic reaction

Page 191: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 191

Intramuscular InjectionsIntramuscular Injections

1. Administered into muscular layer of the body

a. Located below skin and SC layer

b. Angle of insertion: 90 degrees to patient’s skin

Page 192: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 192

Angle of InsertionAngle of Insertion

Page 193: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 193

Intramuscular Injections, cont. Intramuscular Injections, cont.

2. Amount that can be injected

a. Gluteal and vastus lateralis sites: • Adults: Up to 3 cc

• Very thin adults and older patients: Up to 2 cc

b. Deltoid site: no more than 1 cc

Page 194: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 194

Intramuscular Injections, cont. Intramuscular Injections, cont.

3. Absorption more rapid than SC

a. More blood vessels in muscle tissue

4. Medication that is irritating to SC tissue: often given through IM route

a. Fewer nerve endings in muscle tissue

Page 195: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 195

Intramuscular Injections, cont. Intramuscular Injections, cont.

5. Most parenteral medications: administered IM

a. Medications administered IM in medical office:• Immunizations

• Antibiotics

• Injectable contraceptives

• Vitamin B12

• Corticosteroids

Page 196: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 196

Intramuscular Injections, cont. Intramuscular Injections, cont.

6. Needle length range: 1 to 3 inches

Must be long enough to reach muscle tissue

a. Average-sized adult: typically use 1½ inches

b. Child or thin adult: 1 inch

c. Obese patient: 2 inches or more depending on amount of SC tissue

Page 197: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 197

Intramuscular Injections, cont. Intramuscular Injections, cont.

7. Needle gauge range: 18 to 23

a. Depends upon viscosity of medication

8. Intramuscular Injection Sites

a. Located away from large nerves and blood vessels

b. Should be fully exposed• Permits clear visualization of site

Page 198: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 198

Dorsogluteal Site Dorsogluteal Site

c. Dorsogluteal Site• Gluteal muscles are well-developed: can

absorb large amount of medication

• Used for:

– Adults

– Children older than 3 years of age

• Patient position: on abdomen with toes pointed inward (relaxes gluteal muscles)

Page 199: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 199

Dorsogluteal Site, cont. Dorsogluteal Site, cont.

• Inject medication into upper outer quadrant of gluteal area

– Located: above a diagonal line drawn from greater trochanter to posterior superior iliac spine

– Identify landmarks through palpation

• Be extremely careful to maintain proper boundary lines

– To avoid injection into sciatic nerve or superior gluteal artery

Page 200: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 200

Dorsogluteal SiteDorsogluteal Site

From Leahy JM, Kizilay PE: Foundations of Nursing Practice: A Nursing Process Approach. Philadelphia, 1988, Saunders.

Page 201: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 201

Deltoid Site Deltoid Site

d. Deltoid Site• Easily accessible

• Patient position: sitting or lying down

• Amount: no more than 1 cc should be administered

Page 202: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 202

Deltoid Site, cont. Deltoid Site, cont.

• Site is small because major nerves and blood vessels surround it

– Cannot administer large amount of medication

– Cannot administer repeated injections

• Make sure entire arm is exposed

– Completely pull up sleeve

– If cannot pull up sleeve: remove arm from sleeve

1) Tight sleeve constricts arm: causes bleeding from puncture site

Page 203: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 203

Deltoid Site, cont.Deltoid Site, cont.

• To locate site:

– Palpate lower edge of acromion process

– Forms the base of a triangle in line with midpoint of lateral side of arm, opposite the axilla

– Can also be located by placing four fingers horizontally across the deltoid muscle with top finger along acromion process; site located three finger widths below acromion process

Page 204: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 204

Deltoid SiteDeltoid Site

From Leahy JM, Kizilay PE: Foundations of Nursing Practice: A Nursing Process Approach. Philadelphia, 1988, Saunders.

Page 205: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 205

Vastus Lateralis Site Vastus Lateralis Site

e. Vastus Lateralis Site• Thick muscle away from major nerves and

blood vessels

• Recommended for: infants and children younger than 3 years

– Gluteal muscles are not well developed yet

Page 206: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 206

Vastus Lateralis Site, cont. Vastus Lateralis Site, cont.

• To locate site:

– Proximal boundary: hand's breadth below greater trochanter

– Distal boundary: hand's breadth above the knee

– Bounded by midanterior thigh on the front of the leg and midlateral thigh on the side of the leg

• Patient position: Easier to give lying down but patient can be sitting

Page 207: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 207

Vastus Lateralis SiteVastus Lateralis Site

From Leahy JM, Kizilay PE: Foundations of Nursing Practice: A Nursing Process Approach. Philadelphia, 1988, Saunders.

Page 208: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 208

Ventrogluteal Site Ventrogluteal Site

f. Ventrogluteal site• Growing in acceptability because:

– SC layer is small at this site

– Muscle layer is thick

– Located away from major nerves and blood vessels

Page 209: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 209

Ventrogluteal SiteVentrogluteal Site

From Leahy JM, Kizilay PE: Foundations of Nursing Practice: A Nursing Process Approach. Philadelphia, 1988, Saunders.

Page 210: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 210

Z-Track Method Z-Track Method

9. Z-Track Method

a. Used for administering medication that:• Irritate SC tissue

• Discolor skin

– Example: iron dextran injection

Page 211: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 211

Z-Track Method, cont. Z-Track Method, cont.

b. Sites used• Dorsoglutel

• Ventrogluteal

• Vastus lateralis

Page 212: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 212

Z-Track Method, cont. Z-Track Method, cont.

c. To administer injection:• Pull skin and SC tissue to the side

• Administer injection and remove needle

• Release skin: causes a zigzag path through tissue

– Seals off needle track

1) Prevents medication from reaching SC layer or skin surface

Page 213: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 213

Z-Track MethodZ-Track Method

Page 214: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 214

What Would You Do?What Would You Not Do?

What Would You Do?What Would You Not Do?

Page 215: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 215

What Would You Do?What Would You Not Do?

What Would You Do?What Would You Not Do?

Page 216: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 216

Intradermal InjectionsIntradermal Injections

1. Administered in dermal layer of skin

a. Angle of insertion: almost parallel to skin

Page 217: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 217

Intradermal Injections, cont. Intradermal Injections, cont.

2. Absorption is slow:

a. Only small amount of medication can be injected• 0.01 to 0.2 cc

Page 218: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 218

Intradermal Injections, cont. Intradermal Injections, cont.

3. ID injection sites: where skin is thin

a. Anterior forearm

b. Middle of back

c. Upper arm

4. Needle length range: ⅜ to ⅝ inch

5. Needle gauge range: 25 to 27

Page 219: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 219

Intradermal Injections, cont. Intradermal Injections, cont.

6. Tuberculin syringe used

a. Capacity of syringe is small: 1 cc

b. Calibrations divided into tenths and hundredths of a cubic centimeter• Can administer very small amount of

medication

– Required with an ID injection

Page 220: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 220

Tuberculin SyringeTuberculin Syringe

Page 221: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 221

Intradermal Injections, cont. Intradermal Injections, cont.

7. Used to administer skin tests

a. Allergy tests

b. Tuberculin test

Page 222: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 222

Intradermal Injections, cont. Intradermal Injections, cont.

8. Procedure for skin testing

a. Medication is injected until a wheal forms• Wheal: small raised area because of distention

of skin

Page 223: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 223

Intradermal Injections, cont. Intradermal Injections, cont.

b. Results are read and interpreted at proper time• Allergy tests: 15 to 20 minutes

• Tuberculin test: 48 to 72 hours

Page 224: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 224

Intradermal Injections, cont. Intradermal Injections, cont.

c. If no reaction occurs• Wheal disappears within a short period of time

• Puncture site: only visible sign left

d. Positive reaction: results in induration and erythema• Only criteria used to assess reaction: extent of

induration (not erythema)

Page 225: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 225

Tuberculin TestingTuberculin Testing

1. Infectious disease that usually attacks lungs

2. Caused by: tubercle bacillus (Mycobacterium tuberculosis)

a. Rod-shaped bacterium

Tuberculosis (TB)

Page 226: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 226

Tuberculosis, cont. Tuberculosis, cont.

3. Symptoms

a. Fatigue

b. Weakness

c. Unexplained weight loss

d. Low-grade fever

Page 227: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 227

Tuberculosis, cont. Tuberculosis, cont.

e. Night sweats

f. Cough producing mucopurulent sputum

g. Occasional hemoptysis (coughing up blood)

h. Chest pain

4. Not highly contagious

Page 228: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 228

Tuberculosis, cont. Tuberculosis, cont.

5. Individuals who are infected may not develop disease

a. Body defenses protect them as follows:• Fibrous wall (capsule) builds around TB organisms

• Some bacteria may remain alive in capsule in dormant (inactive) state

• Patient experiences no symptoms

• Cannot spread disease to others

b. Patient is said to have a latent tuberculosis infection (LTBI):• Usually has a positive reaction to TB test

Page 229: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 229

Tuberculosis, cont. Tuberculosis, cont.

6. LTBI may develop into active TB:

a. Shortly after infection or many years after infection

b. TB bacteria break out of capsule: cause symptoms of active TB

c. Occurs in 10% of patients with LTBI

d. Most likely to occur when body defenses are weakened• During a serious illness

• Patients with immune disorder (e.g., AIDS)

Page 230: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 230

Purpose of Tuberculin TestingPurpose of Tuberculin Testing

1. Detect presence of tuberculin infection

2. Recommended for:

a. Patients who have close day-to-day contact with someone who has active TB

b. Individuals who have symptoms of TB

c. Individuals with lowered immunity (e.g., human immunodeficiency virus [HIV])

Page 231: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 231

Purpose of Tuberculin Testing, cont.

Purpose of Tuberculin Testing, cont.

3. Used as screening measure for early detection of TB (before patient becomes symptomatic)

a. Early treatment: helps prevent spread of TB

4. May be:

a. Part of health screen

b. Required for:• Employment

• Entrance into college or military

Page 232: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 232

Purpose of Tuberculin Testing, cont.

Purpose of Tuberculin Testing, cont.

5. MA responsible for:

a. Administering TB test

b. Interpreting results

6. MA must follow procedure exactly

a. To ensure accurate test results

b. If not performed correctly:• Patient with TB may not react to test

Page 233: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 233

Tuberculin Test ReactionsTuberculin Test Reactions

1. Tuberculin: Consists of purified protein derivative (PPD)

a. Extracted from a culture of tubercle bacilli• Causative agent of TB

Page 234: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 234

Tuberculin Test Reactions, cont.

Tuberculin Test Reactions, cont.

2. If patient has active or latent TB:

a. Tuberculin causes induration• Induration: abnormally hard spot caused by

accumulation of small sensitized lymphocytes

3. TB test reactions: based on amount of induration present

a. Interpreted according to manufacturer's instructions

Page 235: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 235

Tuberculin Test Reactions, cont.

Tuberculin Test Reactions, cont.

4. Positive reaction: indicates presence of TB infection

a. Does not differentiate between active and latent forms

b. Further diagnostic procedures must be done to make a diagnosis• Chest x-ray study

• Microbiologic examination of sputum

Page 236: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 236

Tuberculin Testing MethodsTuberculin Testing Methods

1. Mantoux test

a. Most commonly used

b. Administered using intradermal needle and syringe

c. More specific and accurate test• Uses a known

amount of tuberculin

Page 237: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 237

Tuberculin Testing Methods, cont.

Tuberculin Testing Methods, cont.

2. Tine test

a. Consists of sterile plastic unit containing four tines• Impregnated with tuberculin

b. Patient inoculated intradermally to a depth of 1 to 2 mm

Page 238: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 238

Tuberculin Testing Methods, cont.

Tuberculin Testing Methods, cont.

c. Disc is pressed onto the skin• Causes tuberculin to be deposited in skin

layers

d. Amount of tuberculin cannot be precisely controlled• Rarely used anymore

Page 239: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 239

Mantoux TestMantoux Test

1. Administered through intradermal injection

a. Using a tuberculin syringe• Needle length: ⅜ to ½ inch

• Needle gauge: 26 to 27

2. Dosage: 0.10 ml of PPD containing 5 TU (tuberculin units)

Page 240: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 240

Mantoux Test, cont. Mantoux Test, cont.

3. Brand names for Mantoux test:

a. Tubersol

b. Aplisol

4. Draw up proper amount of tuberculin solution

a. Too much: may elicit reaction not caused by a TB injection

b. Too little: may be insufficient solution to elicit a reaction

Page 241: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 241

Mantoux Test, cont. Mantoux Test, cont.

5. Inject solution into superficial skin layers to form wheal

a. If injected into SC layer: wheal will not form

b. If injection too shallow: leakage of solution onto skin• If patient has TB: results in false-negative test

• Repeat test: at a site at least 2 inches away

Page 242: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 242

Mantoux TestMantoux Test

Page 243: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 243

Mantoux Test, cont.Mantoux Test, cont.

6. Do not apply pressure after injecting solution

a. Solution not intended to be absorbed into tissues

b. May cause leakage of solution

7. Do not cover site with adhesive bandage

8. Wheal disappears on its own in a few minutes

Page 244: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 244

Guidelines for Administering a Mantoux Test

Guidelines for Administering a Mantoux Test

1. Use anterior forearm: 4 inches below bend in elbow

a. Areas to avoid• Hairy areas

• Areas with visible veins

Page 245: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 245

Guidelines for Administering a Mantoux Test, cont.

Guidelines for Administering a Mantoux Test, cont.

• Scar tissue

• Red, swollen areas

• Bruised areas

• Dermatitis or other skin irritations

Page 246: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 246

Guidelines for Administering a Mantoux Test, cont.

Guidelines for Administering a Mantoux Test, cont.

2. Cleanse site with antiseptic and allow to dry

3. Inject tuberculin into superficial layers of skin

a. Blood at puncture site: will not affect results

4. Read results 48 to 72 hours following administration

Page 247: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 247

Guidelines for Reading Mantoux Test Results

Guidelines for Reading Mantoux Test Results

1. Read in good lighting

2. Use both inspection and palpation to read results

3. If induration is present:• Rub finger lightly from area of normal skin to

indurated area

– To assess size of induration

Page 248: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 248

Guidelines for Reading Mantoux Test Results, cont

Guidelines for Reading Mantoux Test Results, cont

• Measure induration in millimeters

4. Induration: only criteria used to determine a positive reaction

a. If erythema present without induration: results are negative

Page 249: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 249

Guidelines for Reading Mantoux Test Results, cont

Guidelines for Reading Mantoux Test Results, cont

5. Record reaction in mm

a. No induration present: record as 0 mm

6. Never record results as positive or negative

Page 250: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 250

Guidelines for Reading Mantoux Test Results, cont

Guidelines for Reading Mantoux Test Results, cont

7. Interpretation of test results depends on:

a. Measurement of the induration (in mm)

b. Individual's risk of being infected with TB

c. Individual's risk of progression to disease if infected

Page 251: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 251

Guidelines for Reading Mantoux Test Results, cont

Guidelines for Reading Mantoux Test Results, cont

8. Mantoux results interpreted as follows:

a. Positive reaction

• Vesiculation -Strongly positive reaction

– Vesiculation: formation of vesicles that are fluid-containing lesions

• Induration of 10 mm or more: Positive reaction

– Further diagnostic tests required to determine if active TB is present

Page 252: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 252

Guidelines for Reading Mantoux Test Results, cont

Guidelines for Reading Mantoux Test Results, cont

• Induration of 5 mm: Positive for:

– Individual who lives in close contact with person infected with TB

– HIV-infected individual

– Individual at risk for HIV

• Doubtful reaction: Induration of 5 to 9 mm

– Retesting recommended using a different site

• Negative reaction: induration of less than 5mm

Page 253: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 253

Tuberculosis Test Record CardTuberculosis Test Record Card

Page 254: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 254

AllergyAllergy

1. Abnormal hypersensitivity of body to substances that are ordinarily harmless (allergens)a. Allergen: A substance that is capable of

causing an allergic reaction

2. Allergens enter body by:a. Being inhaled

b. Being swallowed

c. Being injected

d. Coming into contact with skin

Page 255: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 255

Allergy, cont. Allergy, cont.

3. Common allergens

a. Plant pollens

b. Molds

c. House dust

d. Animal dander

e. Feather pillows

Page 256: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 256

Allergy, cont. Allergy, cont.

f. Dyes

g. Soaps

h. Detergents

i. Cosmetics

j. Certain foods

k. Medications

l. Insect stings

Page 257: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 257

Allergy, cont. Allergy, cont.

4. Exact cause of allergies: not fully understood

a. May be inherited

5. Allergies can develop at any age

a. Most likely to develop in children

Page 258: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 258

Allergic ReactionAllergic Reaction

1. First time allergen enters body:

a. Stimulates body to produce antibodies (immunoglobulin E antibodies) to the allergen

2. Antibodies combine with allergen: results in allergen-antibody reaction

a. Histamine released in significant amounts• Causes allergic symptoms

b. Respiratory and integumentary systems: most frequently affected

Page 259: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 259

Allergic Reaction, cont. Allergic Reaction, cont.

3. Allergic symptoms

a. Can range from mild to very severe (anaphylactic reaction)

4. Allergies appear in different forms: depends on allergen and body system affected

Page 260: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 260

DiagnosisDiagnosis

1. Best way to prevent allergic reaction:

a. Identify and avoid allergens

2. Detailed medical history: obtained by physician

a. Most important: • Home and work environment

• Diet

• Living habits

Page 261: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 261

Diagnosis, cont. Diagnosis, cont.

3. PE performed to detect conditions resulting from allergies:

a. Nasal polyps

b. Wheezing

c. Skin rashes

d. Urticaria

Page 262: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 262

Diagnosis, cont. Diagnosis, cont.

4. Allergy testing performed

a. Direct skin testing• Skin-prick testing

• Intradermal testing

b. Radioallergosorbent test (RAST)

Page 263: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 263

TreatmentTreatment

5. Treatment

a. Avoidance of allergen (if possible)

b. Drug therapy• Antihistamines

• Decongestants

• Bronchodilators

• Inhaled steroids

c. Allergy injections (desensitization injections)• Decreases sensitivity of body to allergen

Page 264: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 264

Types of Allergy TestsTypes of Allergy Tests

Types of Allergy Tests

1. Purpose of allergy testing: to determine allergens causing patient's symptoms

Page 265: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 265

Direct Skin TestingDirect Skin Testing

1. Extracts of common allergens applied to skin: observed for reaction

• Extracts applied topically

– Patch testing

• Extracts applied into superficial skin layers

– Skin-prick testing

– Intradermal testing

Page 266: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 266

Direct Skin Testing, cont. Direct Skin Testing, cont.

2. Advantage: results obtained immediately

3. Disadvantage: potential to cause adverse reactions

• Most serious: anaphylactic reaction

– Alert physician immediately if occurs

Page 267: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 267

Direct Skin Testing, cont. Direct Skin Testing, cont.

4. Guidelines for Direct Skin Testing

a. Instruct patient to discontinue antihistamines 3 days before testing• Otherwise, false-negative results may occur

b. Area of application must be free from:• Hair

• Scar tissue

• Dermatitis

– Permits good visualization and palpation of test reactions

Page 268: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 268

Direct Skin Testing, cont. Direct Skin Testing, cont.

– Recommended sites:

1)Intradermal skin testing

2)Patch and skin-prick testing

a) Anterior forearm

b) Upper arm

a) Back

Page 269: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 269

Direct Skin Testing, cont. Direct Skin Testing, cont.

c. Cleanse area with antiseptic and allow to dry

d. If testing involves a puncture: wear gloves• To protect against bloodborne pathogens

e. Space extracts 1 inch apart: provides enough area for reaction• If not enough area: large adjacent reactions

may run together

– Difficult to read results

Page 270: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 270

Direct Skin Testing, cont. Direct Skin Testing, cont.

f. Label test sites: • To identify application site when reading

results

g. Inform patient: skin testing may cause a mild allergic reaction• Runny nose

• Sneezing

• Mild wheezing

h. If more severe reaction occurs:• Instruct patient to contact office

Page 271: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 271

Patch TestingPatch Testing

1. Patch Testing:

a. Identifies allergens that cause contact dermatitis

b. Allergens applied to skin using a "patch"• Patch: Small piece of gauze impregnated with

an allergen

– Applied to skin

– Taped in place with hypoallergenic tape

Page 272: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 272

Patch TestPatch Test

Page 273: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 273

Patch Testing, cont. Patch Testing, cont.

c. Allergens commonly applied:• Plants

• Topical drugs

• Resins

• Metals

• Cosmetics

• Dyes

• Chemicals

Page 274: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 274

Patch Testing, cont.Patch Testing, cont.

d. Instruct patient to:• Leave patch in place

• Keep dry

• Return to office in 48 hours to have results read

Page 275: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 275

Patch Testing, cont.Patch Testing, cont.

e. Patches removed: results read 20 minutes later• Allows lessening of redness due to tape

removal

f. Positive results: erythema, itching, induration, vesiculation• Graded on a 1+ to 3+ scoring system

Page 276: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 276

Patch Test ResultsPatch Test Results

Page 277: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 277

Skin Prick Testing Skin Prick Testing

2. Skin-Prick Testing

a. To diagnose allergies to common allergens• Particularly those that are inhaled (house

dust, molds, pollens)

Page 278: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 278

Skin Prick Testing, cont. Skin Prick Testing, cont.

b. Performed by:• Applying allergen extracts to skin

– Number ranges from 20 to 30

• Pricking each with a sterile needle

– Deposits allergen in outer layer of skin

– Allows it to react with body tissues

Page 279: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 279

Skin Prick TestingSkin Prick Testing

Page 280: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 280

Skin Prick Testing, cont. Skin Prick Testing, cont.

c. Guidelines• Place extracts on skin in rows in a specific

pattern

• Label test sites with felt-tipped pen

– Tracks location of each extract

• Place a single drop of extract on skin

– More may cause extracts to run together

Page 281: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 281

Skin Prick Testing, cont.Skin Prick Testing, cont.

• Pass a sterile needle through each drop

– Point of needle should lightly lift top skin layer

• Wipe needle dry with sterile swab between each prick

– Prevents one extract from mixing with the next (causes inaccurate test results)

Page 282: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 282

Skin Prick Testing, cont. Skin Prick Testing, cont.

d. Maximum reaction: occurs in 15 to 20 minutes after pricking skin

e. Leave test sites uncovered; instruct patient not to touch them

f. Do not wipe area: removes extract• Results in false-negative results

g. Read results after 15 to 20 minutes• Using a millimeter ruler

Page 283: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 283

Skin Prick Testing, cont. Skin Prick Testing, cont.

h. Positive reaction: area of induration surrounded by redness and itching

i. Measure size of induration in mm (with mm ruler)• Only criteria used in determining a positive

reaction

• Ignore redness

j. Convert results to a numerical scale (+1, +2, etc.)• Record results

Page 284: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 284

Skin Prick ResultsSkin Prick Results

Page 285: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 285

Intradermal Skin Testing Intradermal Skin Testing

3. Intradermal Skin Testing

a. Similar to skin-prick testing but more specific

b. Number of tests performed: 5 to 30

c. Patients suspected of being highly allergic• Greater chance of adverse allergic reaction

occurring

• Physician usually starts with skin-prick testing

Page 286: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 286

Intradermal Skin Testing, cont. Intradermal Skin Testing, cont.

d. Small amount of allergen extract (0.02 to 0.05 ml)• Injected into skin layers: using a tuberculin

syringe

• Enough extract must be injected to form a wheal

Page 287: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 287

Intradermal Skin Testing, cont. Intradermal Skin Testing, cont.

e. Read reaction in 15 to 20 minutes

f. Positive reaction: Induration surrounded by redness and itching

Copyright and courtesy Hollister-Stier, Spokane, Wash.

Page 288: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 288

Intradermal Skin Testing, cont.Intradermal Skin Testing, cont.

g. Measure size of induration in mm (with mm ruler)• Only criteria used in determining a positive

reaction

• Ignore redness

h. Convert to numerical scale based on amount of induration present

Page 289: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 289

Intradermal Test ResultsIntradermal Test Results

Page 290: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 290

RAST TestingRAST Testing

1. Radioallergosorbent test (RAST): measures amount of immunoglobulin E antibodies in blood to common allergens

2. Blood specimen collected and sent to laboratory

3. Blood exposed to radioactively tagged allergens

4. Radiation device measures amounts of immunoglobulin E antibodies to allergens

Page 291: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 291

RAST Testing, cont.RAST Testing, cont.

5. Advantages

a. Results not affected by medications (e.g., antihistamines)

b. No danger of adverse reactions

c. Can be performed on patients with skin eruptions • Unable to undergo direct skin testing

Page 292: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 292

RAST Testing, cont.RAST Testing, cont.

6. Disadvantages• Expensive

• Does not provide immediate results

Page 293: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 293

Outpatient IV TherapyOutpatient IV Therapy

1. Intravenous (IV) therapy

a. Administration of a liquid agent directly into a patient's vein• Distributed throughout the body by way of

circulatory system

b. Veins most commonly used• Peripheral veins of the arm and hand

Page 294: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 294

Outpatient IV Therapy, cont. Outpatient IV Therapy, cont.

c. Liquid IV agents:• Fluids

• Medication

• Nutrients

• Blood or blood products

d. Infusion: Administration of fluids, medications or nutrients through the IV route

e. Transfusion: Administration of whole blood or blood products through the IV route

Page 295: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 295

Outpatient IV Therapy, cont.Outpatient IV Therapy, cont.

2. Most IV therapy takes place in a hospital setting

3. IV therapy is also administered in outpatient ambulatory settings such as:

a. Medical offices and clinics

b. Urgent care centers

c. Ambulatory infusion clinics

d. Patient's home

Page 296: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 296

Outpatient IV Therapy, cont.Outpatient IV Therapy, cont.

4. Advantages of Outpatient IV Therapy

a. More convenient for patient

b. Reduces medical costs • Earlier Hospital Discharge:

– Example: Hospitalized patient with an infection needing IV antibiotics

1) No longer needs to be hospitalized

2) Receives the therapy at an infusion clinic

Page 297: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 297

Outpatient IV Therapy, cont.Outpatient IV Therapy, cont.

• Avoidance of Hospitalization

– Patients with acute or chronic illness that requires IV therapy

– Obtains IV therapy in an outpatient setting

– Can continue daily routine without major interruptions

– More independence and control over condition

– Example: Patient with rheumatoid arthritis needing IV Remicade therapy

1) Receives therapy in rheumatology office

Page 298: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 298

Outpatient IV Therapy, cont. Outpatient IV Therapy, cont.

5. Medical Office-Based IV Therapy

a. Some medical offices provide outpatient IV therapy• Oncology offices: may administer IV

chemotherapy

• Rheumatology offices: may administer IV rheumatology medications

Page 299: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 299

Outpatient IV Therapy, cont.Outpatient IV Therapy, cont.

b. Advantages• Closer monitoring of:

– Patients response to IV therapy

– Adverse reactions

From Potter PA, Perry AG: Basic nursing: essentials for practice, ed 5, St. Louis, 2002, Mosby.

Page 300: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 300

Outpatient IV Therapy, cont. Outpatient IV Therapy, cont.

c. Medical assists must acquire basic knowledge in IV therapy• MA often responsible for:

– Scheduling IV therapy

– Providing patient instructions

– Answering questions

Page 301: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 301

Outpatient IV Therapy, cont.Outpatient IV Therapy, cont.

d. Requirements for MA to perform IV therapy:• Check the laws of his or her state

– Determine if legally permissible for MA to perform this procedure

• Acquire proper training (theory and skills)

Page 302: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 302

Indications for Outpatient IV Therapy

Indications for Outpatient IV Therapy

1. Physician assesses need for outpatient IV therapy:

a. Patients condition warrants the use of IV therapy

b. No alternate routes are feasible or appropriate

c. Patient does not need to be hospitalized to receive IV therapy

Page 303: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 303

Indications for Outpatient IV Therapy, cont.

Indications for Outpatient IV Therapy, cont.

2. Physician is responsible for:

a. Prescribing IV medication/fluid and treatment plan

b. Ordering laboratory tests to monitor patients progress

c. Assessing patient following IV therapy

Page 304: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 304

Indications for Outpatient IV Therapy, cont.

Indications for Outpatient IV Therapy, cont.

3. IV therapy administered at an outpatient site other than medical office (e.g., infusion clinic)a. MA responsibilities:

• Scheduling the necessary services

• Providing patient with IV therapy instructions

– Length of time required for the therapy

– Any dietary restrictions

– Advising the patient to wear loose-fitting comfortable clothing

– Whether or not someone needs to transport patient to/from appointment

Page 305: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 305

Indications for Outpatient IV Therapy, cont.

Indications for Outpatient IV Therapy, cont.

4. IV therapy administered at the medical office

a. Special room to deliver the therapy• Lounge chair for patient comfort

b. Entry-level MA responsibilities:• Scheduling IV therapy

• Providing IV therapy instructions

Page 306: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 306

Indications for Outpatient IV Therapy, cont.

Indications for Outpatient IV Therapy, cont.

c. IV practitioner (e.g., nurse or specially-trained medical assistant)• Initiates, maintains and discontinues the IV

therapy

Photo by Margaret Hartshorn; Courtesy of the Arizona Arthritis Center(www.arthritis.arizona.edu)

Page 307: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 307

Indications for Outpatient IV Therapy, cont.

Indications for Outpatient IV Therapy, cont.

• Must be completely familiar with IV therapy including:

– Indications and uses

– Actions

– Dosage and rate of infusion

– Incompatibilities

– Contraindications and precautions

– Antidote

– Adverse effects

Page 308: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 308

Indications for Outpatient IV Therapy, cont.

Indications for Outpatient IV Therapy, cont.

• During the IV therapy:

– Monitor patient response to therapy

– Be alert for adverse or allergic reactions

• After the therapy:

– Provide follow-up instructions

1) Normal side effects once patient returns home

2) Adverse reactions to report to medical office

Page 309: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 309

Indications for Outpatient IV Therapy, cont.

Indications for Outpatient IV Therapy, cont.

5. Indications for IV therapy in an outpatient setting:

a. Administration of IV medication

b. Replacement of fluids and electrolytes

c. Administration of nutritional supplements

d. Administration of blood products

e. Emergency administration of IV medications and fluids

Page 310: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 310

Administration of IV Medication

Administration of IV Medication

1. Process of delivering medication directly into a vein

a. Rapid and effective

b. Provides more accurate dosing than other routes• Medication enters the body directly from

circulatory system

Page 311: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 311

Administration of IV Medication, cont.

Administration of IV Medication, cont.

– Bypasses barriers to drug absorption

1) Digestive tract: from oral administration

2) Muscle tissue: from IM administration

– Easier to control actual amount of drug delivered to the body

Page 312: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 312

Administration of IV Medication, cont.

Administration of IV Medication, cont.

2. Medication may have to be administered through the IV route because:

a. Rapid systemic response to medication is desired

b. Therapeutic blood levels need to be maintained

c. Medication is destroyed by stomach acids and/or digestive enzymes

d. Medication cannot be absorbed into body through GI tract

e. Medication is toxic and could damage to lining of GI tract

f. Medication is painful or irritating when given by other parenteral routes (IM or SC)

Page 313: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 313

Direct IV InjectionDirect IV Injection

3. IV Administration Methods

a. Direct IV Injection (IV push)• Administration of medication as a single dose

into the vein over a short period of time (usually less than 10 minutes)

– Administered through a vascular access device already in place

• Immediate and predictable results

• Good way to administer life-saving medications in an emergency

Page 314: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 314

Intermittent IV AdministrationIntermittent IV Administration

b. Intermittent IV Administration• Administration of a medication over a specific

amount of time (termed the rate of infusion) and at specified intervals

• Frequently employed in outpatient settings

• Before administering

Page 315: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 315

Intermittent IV Administration, cont.

Intermittent IV Administration, cont.

– Dilute medication in a moderate amount of IV fluid (25 to 250 ml)

– Amount and type of IV fluid: indicated in drug insert

1) Example: Intermittent IV administration of ceftriaxone (an antibiotic) a) Reconstitute medication

b) Dilute in 50 to 100 ml of an IV fluid (e.g., sterile water, 0.9% sodium chloride)

Page 316: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 316

Intermittent IV Administration, cont.

Intermittent IV Administration, cont.

• Rate of infusion: Depends on medication being administered

– Typically ranges from 15 minutes to several hours

– Specified in drug insert

1) Examples: a) Rate of infusion for

ceftriaxone (Rocephin): Between 15 to 30 minutes

b) Rate of infusion for IV infliximab (Remicade): At least 2 hours

Page 317: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 317

Intermittent IV Administration, cont.

Intermittent IV Administration, cont.

• Interval of time between doses depends on:

– Medication being administered

– Patient condition

1) Example: Outpatient treatment plan for a patient with Lyme disease

a) IV ceftriaxone intermittently once a day for a period of 14 days

Page 318: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 318

Continuous IV AdministrationContinuous IV Administration

c. Continuous IV Administration• Infusion of medication over a continuous

period of time (between 4 to 24 hours)

• Also known as an IV drip

• Most often used in hospital or home setting

• Used to maintain a constant therapeutic blood level of the medication

Page 319: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 319

Continuous IV Administration, cont.

Continuous IV Administration, cont.

• Medication is diluted in a large quantity (250 to 1000 ml) of an IV fluid such as:

– 0.9% sodium chloride (known as normal saline)

– 5% dextrose in water (known as D5W)

• Not generally used to administer IV medications in medical office

– Because of amount of time required

Page 320: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 320

IV Medication: AntibioticsIV Medication: Antibiotics

4. Intravenous Medications Administered in an Outpatient Setting

a. IV Antibiotics• May be prescribed to treat a serious infection

– To prevent the infection from spreading

– To avoid the development of serious complications

Page 321: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 321

IV Medication: Antibiotics, cont.

IV Medication: Antibiotics, cont.

• Quickly achieves high blood concentrations

– Works on the infection immediately.

• IV antibiotic therapy may be prescribed in an outpatient setting for:

– Osteomyelitis, cellulitis endocarditis, bacterial meningitis, Lyme disease, bacterial pneumonia, bacterial septicemia, pyelonephritis, pelvic inflammatory disease, AIDS-related infections, severe urinary tract infections, and non-healing wound infections

Page 322: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 322

IV Medication: ChemotherapyIV Medication: Chemotherapy

b. IV Chemotherapy

• Chemotherapy: the use of chemicals to treat disease.

– More specifically: the use of antineoplastic medications to treat different types of cancer

• Works by interfering with the ability of cancer cells to grow or reproduce

Page 323: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 323

IV Medication: Chemotherapy, cont.

IV Medication: Chemotherapy, cont.

• IV route commonly used to administer chemotherapy

– Most antineoplastic medications are toxic and irritating

– Must be delivered to the body through a vein

– Cause pain and trauma to tissues if administered by other parenteral routes (i.e.; IM or SC)

Page 324: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 324

IV Medication: Chemotherapy, cont.

IV Medication: Chemotherapy, cont.

• May take only a few minutes to administer or as long as several hours

• May be given on a daily, weekly or monthly basis

• Frequency and length of treatment depends on:

– Type of cancer

– Antineoplastic medications being administered

– Patient’s overall health

– Patients to tolerate the antineoplastic medications

Page 325: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 325

IV Medication: Chemotherapy, cont.

IV Medication: Chemotherapy, cont.

• Often administered in an outpatient setting such as:

– Oncology medical office

– Infusion clinic

Page 326: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 326

IV Medication: Monoclonal Antibodies

IV Medication: Monoclonal Antibodies

c. Monoclonal Antibodies• Used to treat inflammatory diseases

• Individuals with certain inflammatory diseases

– Have too much of a normally-occurring protein (tumor necrosis factor [TNF])

1) Causes inflammation

2) In too large of amounts: attacks healthy tissues

Page 327: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 327

IV Medication: Monoclonal Antibodies, cont.

IV Medication: Monoclonal Antibodies, cont.

• Remicade (infliximab) is a monoclonal antibody which works by:

– Binding with TNF and blocking its action

1) Reduces the inflammatory response of the body

2) Disadvantage: Also lowers ability of body to fight infection

Page 328: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 328

IV Medication: Monoclonal Antibodies, cont.

IV Medication: Monoclonal Antibodies, cont.

• IV Remicade administered in an outpatient setting for treatment of:

– Crohn's disease

– Rheumatoid arthritis

– Ulcerative colitis

– Ankylosing spondylitis

– Psoriatic arthritis

Page 329: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 329

IV Medication: Monoclonal Antibodies, cont.

IV Medication: Monoclonal Antibodies, cont.

• Remicade works to:

– Reduce the symptoms

– Initiate and maintain remission of the disorder

• IV Remicade only administered after an inadequate response to conventional therapy

– Has some undesirable side effects

– Expensive

Page 330: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 330

IV Medication: AnalgesicsIV Medication: Analgesics

d. IV Analgesics• May be prescribed if patient is unable to

manage pain using oral pain medications

• IV analgesic therapy may be prescribed in an outpatient setting for:

– Migraine headaches

– Cancer-related pain

– Pain associated with AIDs conditions

Page 331: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 331

IV Medication: Analgesics, cont.

IV Medication: Analgesics, cont.

• Patient-controlled analgesia (PCA) pump

– Used to administer IV narcotic analgesics

– Delivery of the medication controlled by patient

– When patient experiences pain

1) Presses a button on PCA pump

2) Predetermined dose delivered IV to patient

– Pump is preset: to prevent overmedication

– Includes a locking device for security of the medication

Page 332: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 332

PCA PumpPCA Pump

From Elkin MK, Perry AG, Potter PA: Nursing interventions and clinical skills, ed 3, St. Louis, 2004, Mosby.

Page 333: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 333

Replacement of Fluids and Electrolytes

Replacement of Fluids and Electrolytes

1. To remain healthy: Body must maintain adequate fluid and electrolyte balance

2. Depletion of fluids and electrolytes may be caused by:

a. Vomiting

b. Diarrhea

c. Excessive perspiration (e.g., fever breaking or hot weather)

d. Starvation

Page 334: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 334

Replacement of Fluids and Electrolytes, cont.

Replacement of Fluids and Electrolytes, cont.

3. Excessive loss of fluids or electrolytes

a. Must be replaced as soon as possible to prevent dehydration• Infants and children: Especially vulnerable to

dehydration

Page 335: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 335

Replacement of Fluids and Electrolytes, cont.

Replacement of Fluids and Electrolytes, cont.

4. Best way to replace fluids and electrolytes: oral consumption

a. May not be possible (e.g., excessive vomiting)• IV fluid therapy may be prescribed

Page 336: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 336

Replacement of Fluids and Electrolytes, cont.

Replacement of Fluids and Electrolytes, cont.

5. Physician determines the IV fluid/amount using the following information:

a. Patient's diagnosis (e.g., prolonged diarrhea)

b. Other existing medical conditions

c. Length of the current illness

d. Body size and weight

e. Physician's findings from physical examination

f. Laboratory test results

Page 337: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 337

Replacement of Fluids and Electrolytes, cont.

Replacement of Fluids and Electrolytes, cont.

6. Examples of IV fluids used to replace fluids/electrolytes:

a. 0.9% sodium chloride

b. Ringer's solution

Page 338: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 338

Replacement of Fluids and Electrolytes, cont.

Replacement of Fluids and Electrolytes, cont.

7. Administered by continuous IV administration in following outpatient settings: a. Urgent care centers

b. Infusion clinics

c. Patient's home

8. Medical office does not typically administer IV fluids/electrolytes except in an emergencya. Because of length of time required for

continuous IV administration

Page 339: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 339

Administration of Nutritional Supplements

Administration of Nutritional Supplements

1. IV therapy used to administer nutritional supplements in an outpatient setting

a. Indications:• Patient unable to eat

• Conditions causing poor absorption of nutrients from GI tract

b. Only used when patient has a condition that prevents other routes of administration (e.g., oral or enteral route)

Page 340: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 340

Administration of Nutritional Supplements, cont.

Administration of Nutritional Supplements, cont.

• Enteral nutrition: The delivery of nutrients through a tube inserted into the GI tract.

2. May require IV administration of nutritional supplements:

a. Ulcerative colitis, Crohn’s disease, short bowel syndrome, celiac disease, pancreatitis, esophageal cancer, AIDS-related malnutrition, and malnutrition related to an eating disorder

3. Parenteral IV nutrition is often administered in outpatient settings (e.g., infusion clinics and the patient's home)

Page 341: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 341

Administration of Blood Products

Administration of Blood Products

1. Immune Globulin

a. Consists of pooled human plasma containing antibodies• Has been tested

– Found to be safe and free of bloodborne pathogens

• Must be given through IV route

b. Intravenous immune globulin (IVIG) therapy

Page 342: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 342

Administration of Blood Products, cont.

Administration of Blood Products, cont.

• Used to treat:

– Immune deficiencies who are unable to produce their own antibodies

1) Chronic inflammatory demyelinating polyneuropathy (CIDP)

a) Autoimmune disease: A condition in which, for some unknown reason, the body's immune system attacks the body's own cells such as:o Multiple sclerosis

o Myasthenia gravis

o Lupus

Page 343: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 343

Administration of Blood Products, cont.

Administration of Blood Products, cont.

c. IVIG treatment plan• Dose is based on patient's weight

• Medication is infused slowly over a number of hours

• Number and frequency of treatment depends on patient condition.

– Patient who cannot produce antibodies: IVIG treatment once a month

– Patient with autoimmune disease: may only require a treatment when there is a flare-up (to boost immune system)

Page 344: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 344

Administration of Blood Products, cont.

Administration of Blood Products, cont.

2. Hemophilia Factorsa. Hemophilia: An inherited bleeding

disorder characterized by a deficiency of a clotting factor needed for proper coagulation of the blood;

b. Without this factor• Hemophiliac may bleed:

– Spontaneously

– Following trauma to any tissues or organs of the body

• Most common sites of bleeds: Joints and muscles

Page 345: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 345

Administration of Blood Products, cont.

Administration of Blood Products, cont.

c. Missing blood clotting factor: must periodically be administered IV

d. If treatment delayed: • Irreversible damage to affected tissues

• Death

e. Many patients receive IV clotting factors at home• More convenient

• Easier to manage condition

Page 346: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 346

Emergency Administration of IV Medication and Fluids

Emergency Administration of IV Medication and Fluids

1. Capability to initiate an IV line is important in an emergency

a. Provides an access route for IV administration of:• Life-saving medications

• Fluids

Page 347: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 347

Emergency Administration of IV Medication and Fluids, cont. Emergency Administration of

IV Medication and Fluids, cont.

2. Emergency situations sometimes arise in medical office

a. While waiting for squad to transport patient to hospital• IV line may be established to administer

medications and fluids as soon as possible

Page 348: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 348

Emergency Administration of IV Medication and Fluids, cont.Emergency Administration of

IV Medication and Fluids, cont.

b. Emergency situations which may benefit from establishing IV access: • Myocardial infarction

• Stroke

• Anaphylactic reaction

• Diabetic emergencies

• Heat-related injuries (e.g., heat stroke)

Page 349: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 349

POSTTESTPOSTTEST

True or False1. OSHA is responsible for determining if drugs are

safe before release for human use.

2. An enteric-coated tablet does not dissolve until it reaches the intestines.

3. The apothecary system is most often used to administer medication in the medical office.

4. The parenteral route of administering medications is used when the patient is allergic to the oral form of the drug.

5. Hypodermic syringes are calibrated in cubic centimeters.

Page 350: CHAPTER 11 ADMINISTRATION OF MEDICATION AND INTRAVENOUS THERAPY

Elsevier items and derived items © 2008 by Saunders, an imprint of Elsevier Inc. 350

POSTTEST, CONT.POSTTEST, CONT.

True or False6. The maximum amount of medication that can be

administered through the subcutaneous route is 2 cc.

7. A patient with latent tuberculosis infection has a negative reaction to a TB test.

8. A tuberculin skin test result should be read 15 to 20 minutes after administering.

9. Intermittent IV administration involves the administration of IV medication over a specific amount of time at specified intervals.

10. Immune globulin consists of pooled human plasma that contains clotting factors.